Global and United States Small Molecule Active Pharmaceutical Ingredient Market Report & Forecast 2022-2028

Global and United States Small Molecule Active Pharmaceutical Ingredient Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Small Molecule Active Pharmaceutical Ingredient Product Introduction
1.2 Global Small Molecule Active Pharmaceutical Ingredient Outlook 2017 VS 2022 VS 2028
1.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales in US$ Million for the Year 2017-2028
1.2.2 Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume for the Year 2017-2028
1.3 United States Small Molecule Active Pharmaceutical Ingredient Outlook 2017 VS 2022 VS 2028
1.3.1 United States Small Molecule Active Pharmaceutical Ingredient Sales in US$ Million for the Year 2017-2028
1.3.2 United States Small Molecule Active Pharmaceutical Ingredient Sales in Volume for the Year 2017-2028
1.4 Small Molecule Active Pharmaceutical Ingredient Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Small Molecule Active Pharmaceutical Ingredient in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Small Molecule Active Pharmaceutical Ingredient Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Small Molecule Active Pharmaceutical Ingredient Market Dynamics
1.5.1 Small Molecule Active Pharmaceutical Ingredient Industry Trends
1.5.2 Small Molecule Active Pharmaceutical Ingredient Market Drivers
1.5.3 Small Molecule Active Pharmaceutical Ingredient Market Challenges
1.5.4 Small Molecule Active Pharmaceutical Ingredient Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Small Molecule Active Pharmaceutical Ingredient Market Segment by Type
2.1.1 Standard API
2.1.2 High Potency API
2.2 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Type
2.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Small Molecule Active Pharmaceutical Ingredient Market Size by Type
2.3.1 United States Small Molecule Active Pharmaceutical Ingredient Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Small Molecule Active Pharmaceutical Ingredient Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Small Molecule Active Pharmaceutical Ingredient Market Segment by Application
3.1.1 Cardiovascular Diseases
3.1.2 Respiratory Disorders
3.1.3 Infectious Diseases
3.1.4 Others
3.2 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Application
3.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Small Molecule Active Pharmaceutical Ingredient Market Size by Application
3.3.1 United States Small Molecule Active Pharmaceutical Ingredient Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Small Molecule Active Pharmaceutical Ingredient Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Small Molecule Active Pharmaceutical Ingredient Competitor Landscape by Company
4.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Company
4.1.1 Top Global Small Molecule Active Pharmaceutical Ingredient Manufacturers Ranked by Revenue (2021)
4.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturer (2017-2022)
4.1.3 Global Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturer (2017-2022)
4.1.4 Global Small Molecule Active Pharmaceutical Ingredient Price by Manufacturer (2017-2022)
4.2 Global Small Molecule Active Pharmaceutical Ingredient Concentration Ratio (CR)
4.2.1 Small Molecule Active Pharmaceutical Ingredient Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Small Molecule Active Pharmaceutical Ingredient in 2021
4.2.3 Global Small Molecule Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Small Molecule Active Pharmaceutical Ingredient Manufacturing Base Distribution, Product Type
4.3.1 Global Small Molecule Active Pharmaceutical Ingredient Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
4.3.3 Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Small Molecule Active Pharmaceutical Ingredient Market Size by Company
4.5.1 Top Small Molecule Active Pharmaceutical Ingredient Players in United States, Ranked by Revenue (2021)
4.5.2 United States Small Molecule Active Pharmaceutical Ingredient Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Small Molecule Active Pharmaceutical Ingredient Sales by Players (2020, 2021 & 2022)
5 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Region
5.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Small Molecule Active Pharmaceutical Ingredient Market Size in Volume by Region (2017-2028)
5.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Region: 2017-2022
5.2.2 Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume Forecast by Region (2023-2028)
5.3 Global Small Molecule Active Pharmaceutical Ingredient Market Size in Value by Region (2017-2028)
5.3.1 Global Small Molecule Active Pharmaceutical Ingredient Sales in Value by Region: 2017-2022
5.3.2 Global Small Molecule Active Pharmaceutical Ingredient Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2017-2028
6.1.2 North America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2017-2028
6.3.2 Europe Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2017-2028
6.4.2 Latin America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Johnson Matthey
7.1.1 Johnson Matthey Corporation Information
7.1.2 Johnson Matthey Description and Business Overview
7.1.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Products Offered
7.1.5 Johnson Matthey Recent Development
7.2 Siegfried Holding AG
7.2.1 Siegfried Holding AG Corporation Information
7.2.2 Siegfried Holding AG Description and Business Overview
7.2.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
7.2.5 Siegfried Holding AG Recent Development
7.3 Pfizer
7.3.1 Pfizer Corporation Information
7.3.2 Pfizer Description and Business Overview
7.3.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Pfizer Small Molecule Active Pharmaceutical Ingredient Products Offered
7.3.5 Pfizer Recent Development
7.4 Sanofi S.A.
7.4.1 Sanofi S.A. Corporation Information
7.4.2 Sanofi S.A. Description and Business Overview
7.4.3 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Products Offered
7.4.5 Sanofi S.A. Recent Development
7.5 Novartis AG,
7.5.1 Novartis AG, Corporation Information
7.5.2 Novartis AG, Description and Business Overview
7.5.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Products Offered
7.5.5 Novartis AG, Recent Development
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Corporation Information
7.6.2 Bristol-Myers Squibb Description and Business Overview
7.6.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Products Offered
7.6.5 Bristol-Myers Squibb Recent Development
7.7 Boehringer Ingelheim GmbH
7.7.1 Boehringer Ingelheim GmbH Corporation Information
7.7.2 Boehringer Ingelheim GmbH Description and Business Overview
7.7.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Products Offered
7.7.5 Boehringer Ingelheim GmbH Recent Development
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporation Information
7.8.2 GlaxoSmithKline Description and Business Overview
7.8.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.8.4 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Products Offered
7.8.5 GlaxoSmithKline Recent Development
7.9 Albany Molecular Research Inc.
7.9.1 Albany Molecular Research Inc. Corporation Information
7.9.2 Albany Molecular Research Inc. Description and Business Overview
7.9.3 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Products Offered
7.9.5 Albany Molecular Research Inc. Recent Development
7.10 Bachem Holding AG
7.10.1 Bachem Holding AG Corporation Information
7.10.2 Bachem Holding AG Description and Business Overview
7.10.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
7.10.5 Bachem Holding AG Recent Development
7.11 PCAS
7.11.1 PCAS Corporation Information
7.11.2 PCAS Description and Business Overview
7.11.3 PCAS Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.11.4 PCAS Small Molecule Active Pharmaceutical Ingredient Products Offered
7.11.5 PCAS Recent Development
7.12 Patheon N.V.
7.12.1 Patheon N.V. Corporation Information
7.12.2 Patheon N.V. Description and Business Overview
7.12.3 Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Patheon N.V. Products Offered
7.12.5 Patheon N.V. Recent Development
7.13 AstraZeneca
7.13.1 AstraZeneca Corporation Information
7.13.2 AstraZeneca Description and Business Overview
7.13.3 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.13.4 AstraZeneca Products Offered
7.13.5 AstraZeneca Recent Development
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Corporation Information
7.14.2 Johnson & Johnson Description and Business Overview
7.14.3 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Johnson & Johnson Products Offered
7.14.5 Johnson & Johnson Recent Development
7.15 Merck & Co
7.15.1 Merck & Co Corporation Information
7.15.2 Merck & Co Description and Business Overview
7.15.3 Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Merck & Co Products Offered
7.15.5 Merck & Co Recent Development
7.16 BASF SE
7.16.1 BASF SE Corporation Information
7.16.2 BASF SE Description and Business Overview
7.16.3 BASF SE Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.16.4 BASF SE Products Offered
7.16.5 BASF SE Recent Development
7.17 Catalent Inc.
7.17.1 Catalent Inc. Corporation Information
7.17.2 Catalent Inc. Description and Business Overview
7.17.3 Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Catalent Inc. Products Offered
7.17.5 Catalent Inc. Recent Development
7.18 Teva Pharmaceuticals
7.18.1 Teva Pharmaceuticals Corporation Information
7.18.2 Teva Pharmaceuticals Description and Business Overview
7.18.3 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Teva Pharmaceuticals Products Offered
7.18.5 Teva Pharmaceuticals Recent Development
7.19 Roche
7.19.1 Roche Corporation Information
7.19.2 Roche Description and Business Overview
7.19.3 Roche Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Roche Products Offered
7.19.5 Roche Recent Development
7.20 Cambrex Corporation
7.20.1 Cambrex Corporation Corporation Information
7.20.2 Cambrex Corporation Description and Business Overview
7.20.3 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.20.4 Cambrex Corporation Products Offered
7.20.5 Cambrex Corporation Recent Development
7.21 GILEAD Science Inc.
7.21.1 GILEAD Science Inc. Corporation Information
7.21.2 GILEAD Science Inc. Description and Business Overview
7.21.3 GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
7.21.4 GILEAD Science Inc. Products Offered
7.21.5 GILEAD Science Inc. Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Small Molecule Active Pharmaceutical Ingredient Industry Chain Analysis
8.2 Small Molecule Active Pharmaceutical Ingredient Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Small Molecule Active Pharmaceutical Ingredient Distributors
8.3 Small Molecule Active Pharmaceutical Ingredient Production Mode & Process
8.4 Small Molecule Active Pharmaceutical Ingredient Sales and Marketing
8.4.1 Small Molecule Active Pharmaceutical Ingredient Sales Channels
8.4.2 Small Molecule Active Pharmaceutical Ingredient Distributors
8.5 Small Molecule Active Pharmaceutical Ingredient Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Small Molecule Active Pharmaceutical Ingredient CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Small Molecule Active Pharmaceutical Ingredient Market Trends
Table 3. Small Molecule Active Pharmaceutical Ingredient Market Drivers
Table 4. Small Molecule Active Pharmaceutical Ingredient Market Challenges
Table 5. Small Molecule Active Pharmaceutical Ingredient Market Restraints
Table 6. Global Small Molecule Active Pharmaceutical Ingredient Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Small Molecule Active Pharmaceutical Ingredient Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Small Molecule Active Pharmaceutical Ingredient Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Small Molecule Active Pharmaceutical Ingredient Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Small Molecule Active Pharmaceutical Ingredient Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturer, 2017-2022
Table 13. Global Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturer, (MT), 2017-2022
Table 14. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Manufacturer, 2017-2022
Table 15. Global Small Molecule Active Pharmaceutical Ingredient Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Small Molecule Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Small Molecule Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Active Pharmaceutical Ingredient as of 2021)
Table 18. Top Players of Small Molecule Active Pharmaceutical Ingredient in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
Table 20. Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Small Molecule Active Pharmaceutical Ingredient Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Small Molecule Active Pharmaceutical Ingredient Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Small Molecule Active Pharmaceutical Ingredient Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Small Molecule Active Pharmaceutical Ingredient Sales by Players, (MT), 2020, 2021 & 2022
Table 26. United States Small Molecule Active Pharmaceutical Ingredient Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Small Molecule Active Pharmaceutical Ingredient Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Region (2017-2022) & (MT)
Table 29. Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume Forecast by Region (2023-2028) & (MT)
Table 30. Global Small Molecule Active Pharmaceutical Ingredient Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Small Molecule Active Pharmaceutical Ingredient Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028) & (MT)
Table 33. North America Small Molecule Active Pharmaceutical Ingredient Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Region (2017-2028) & (MT)
Table 35. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028) & (MT)
Table 37. Europe Small Molecule Active Pharmaceutical Ingredient Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028) & (MT)
Table 39. Latin Americaa Small Molecule Active Pharmaceutical Ingredient Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028) & (MT)
Table 41. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Johnson Matthey Corporation Information
Table 43. Johnson Matthey Description and Business Overview
Table 44. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Product
Table 46. Johnson Matthey Recent Development
Table 47. Siegfried Holding AG Corporation Information
Table 48. Siegfried Holding AG Description and Business Overview
Table 49. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Siegfried Holding AG Product
Table 51. Siegfried Holding AG Recent Development
Table 52. Pfizer Corporation Information
Table 53. Pfizer Description and Business Overview
Table 54. Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Pfizer Product
Table 56. Pfizer Recent Development
Table 57. Sanofi S.A. Corporation Information
Table 58. Sanofi S.A. Description and Business Overview
Table 59. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Sanofi S.A. Product
Table 61. Sanofi S.A. Recent Development
Table 62. Novartis AG, Corporation Information
Table 63. Novartis AG, Description and Business Overview
Table 64. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Novartis AG, Product
Table 66. Novartis AG, Recent Development
Table 67. Bristol-Myers Squibb Corporation Information
Table 68. Bristol-Myers Squibb Description and Business Overview
Table 69. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. Bristol-Myers Squibb Product
Table 71. Bristol-Myers Squibb Recent Development
Table 72. Boehringer Ingelheim GmbH Corporation Information
Table 73. Boehringer Ingelheim GmbH Description and Business Overview
Table 74. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Boehringer Ingelheim GmbH Product
Table 76. Boehringer Ingelheim GmbH Recent Development
Table 77. GlaxoSmithKline Corporation Information
Table 78. GlaxoSmithKline Description and Business Overview
Table 79. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. GlaxoSmithKline Product
Table 81. GlaxoSmithKline Recent Development
Table 82. Albany Molecular Research Inc. Corporation Information
Table 83. Albany Molecular Research Inc. Description and Business Overview
Table 84. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. Albany Molecular Research Inc. Product
Table 86. Albany Molecular Research Inc. Recent Development
Table 87. Bachem Holding AG Corporation Information
Table 88. Bachem Holding AG Description and Business Overview
Table 89. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. Bachem Holding AG Product
Table 91. Bachem Holding AG Recent Development
Table 92. PCAS Corporation Information
Table 93. PCAS Description and Business Overview
Table 94. PCAS Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. PCAS Product
Table 96. PCAS Recent Development
Table 97. Patheon N.V. Corporation Information
Table 98. Patheon N.V. Description and Business Overview
Table 99. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 100. Patheon N.V. Product
Table 101. Patheon N.V. Recent Development
Table 102. AstraZeneca Corporation Information
Table 103. AstraZeneca Description and Business Overview
Table 104. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 105. AstraZeneca Product
Table 106. AstraZeneca Recent Development
Table 107. Johnson & Johnson Corporation Information
Table 108. Johnson & Johnson Description and Business Overview
Table 109. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 110. Johnson & Johnson Product
Table 111. Johnson & Johnson Recent Development
Table 112. Merck & Co Corporation Information
Table 113. Merck & Co Description and Business Overview
Table 114. Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 115. Merck & Co Product
Table 116. Merck & Co Recent Development
Table 117. BASF SE Corporation Information
Table 118. BASF SE Description and Business Overview
Table 119. BASF SE Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 120. BASF SE Product
Table 121. BASF SE Recent Development
Table 122. Catalent Inc. Corporation Information
Table 123. Catalent Inc. Description and Business Overview
Table 124. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 125. Catalent Inc. Product
Table 126. Catalent Inc. Recent Development
Table 127. Teva Pharmaceuticals Corporation Information
Table 128. Teva Pharmaceuticals Description and Business Overview
Table 129. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 130. Teva Pharmaceuticals Product
Table 131. Teva Pharmaceuticals Recent Development
Table 132. Roche Corporation Information
Table 133. Roche Description and Business Overview
Table 134. Roche Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 135. Roche Product
Table 136. Roche Recent Development
Table 137. Cambrex Corporation Corporation Information
Table 138. Cambrex Corporation Description and Business Overview
Table 139. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 140. Cambrex Corporation Product
Table 141. Cambrex Corporation Recent Development
Table 142. GILEAD Science Inc. Corporation Information
Table 143. GILEAD Science Inc. Description and Business Overview
Table 144. GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 145. GILEAD Science Inc. Product
Table 146. GILEAD Science Inc. Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Small Molecule Active Pharmaceutical Ingredient Customers List
Table 150. Small Molecule Active Pharmaceutical Ingredient Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Small Molecule Active Pharmaceutical Ingredient Product Picture
Figure 2. Global Small Molecule Active Pharmaceutical Ingredient Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Small Molecule Active Pharmaceutical Ingredient Market Size 2017-2028 (US$ Million)
Figure 4. Global Small Molecule Active Pharmaceutical Ingredient Sales 2017-2028 (MT)
Figure 5. United States Small Molecule Active Pharmaceutical Ingredient Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Small Molecule Active Pharmaceutical Ingredient Market Size 2017-2028 (US$ Million)
Figure 7. United States Small Molecule Active Pharmaceutical Ingredient Sales 2017-2028 (MT)
Figure 8. United States Small Molecule Active Pharmaceutical Ingredient Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Small Molecule Active Pharmaceutical Ingredient Market Share in Global, in Volume (MT) 2017-2028
Figure 10. Small Molecule Active Pharmaceutical Ingredient Report Years Considered
Figure 11. Product Picture of Standard API
Figure 12. Product Picture of High Potency API
Figure 13. Global Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2022 & 2028
Figure 14. Global Small Molecule Active Pharmaceutical Ingredient Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Small Molecule Active Pharmaceutical Ingredient Sales by Type (2017-2028) & (MT)
Figure 17. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Small Molecule Active Pharmaceutical Ingredient Price by Type (2017-2028) & (USD/MT)
Figure 19. United States Small Mol

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs